LAB
Standard Biotools Inc
0.742$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 56.0% | 52.6% | 46.9% | 53.9% | 48.3% | 53.1% | 45.4% | 51.2% | 51.5% | 57.0% | 46.5% | 47.6% | 50.9% | |
| 44.0% | 47.4% | 53.1% | 46.1% | 51.7% | 46.9% | 54.6% | 48.8% | 48.5% | 43.0% | 53.5% | 52.4% | 49.1% | |
| 25.1% | 24.5% | 35.1% | 32.2% | 29.3% | 30.1% | 26.9% | 28.6% | 32.5% | 32.7% | 10.0% | 9.8% | 21.6% | |
| 87.9% | 75.8% | 103.1% | 167.5% | 76.5% | 80.5% | 191.4% | 129.1% | 136.0% | 106.5% | 88.0% | 81.5% | 102.8% | |
| 127.4% | 123.3% | 185.3% | 180.7% | 122.3% | 117.1% | 174.4% | 157.7% | 168.5% | 135.2% | 98.0% | 178.7% | 143.9% | |
| -83.5% | -75.9% | -132.2% | -134.5% | -70.5% | -70.2% | -119.7% | -108.9% | -120.0% | -92.1% | -44.5% | -126.3% | -94.8% | |
| 4.8% | 3.9% | 2.3% | 3.8% | – | 7.1% | 0.0% | 0.0% | 0.1% | 0.0% | – | – | – | |
| -82.6% | -70.7% | -70.3% | -113.0% | -59.6% | -72.3% | -116.2% | -84.0% | -168.3% | -92.6% | -69.1% | -106.6% | -107.5% | |
| 0.2% | -0.6% | 0.3% | 0.2% | 0.3% | 0.6% | -0.6% | -2.8% | -6.2% | -151.0% | 0.1% | 0.4% | -43.8% | |
| -82.8% | -70.2% | -70.6% | -203.3% | -59.9% | -72.9% | -128.7% | -153.7% | -177.4% | 81.0% | -213.9% | -133.1% | -103.3% | |
| -53.3% | -53.0% | -56.7% | -92.0% | -45.5% | -55.7% | -95.5% | -74.8% | -160.1% | -87.2% | -62.5% | -132.6% | -108.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.